FDA Awards HistoSonics Clearance of its First-of-a-Kind Edison® Histotripsy System
Legacy MEDSearch
OCTOBER 9, 2023
Food and Drug Administration’s (FDA) De Novo Classification Request process, a rigorous pre-market review pathway for medical devices with no existing predicate. was achieved indicating that physicians can precisely target and destroy liver tissue and unresectable liver tumors.
Let's personalize your content